2013 - ISBTS 2013 Symposium


This page contains exclusive content for the member of the following sections: TTS, IXA, ITA. Log in to view.

Posters and Exhibition

15.19 - Ischemic preconditioning applied to the mesenteric artery promotes changes in the expression levels of the inducible nitric oxide synthase, the epidermal growth factor receptor and of the ERK1/2 MAP kinases in intestine and heart tissues of rats submitted

Presenter: Djalma, Fagundes, , Brazil
Authors: Juliana Christina Calado2, Murched Omar Taha1, Djalma Jose Fagundes1, Hugo Pequeno Monteiro2

Ischemic preconditioning applied to the mesenteric artery promotes changes in the expression levels of the inducible nitric oxide synthase, the epidermal growth factor receptor and of the ERK1/2 MAP kinases in intestine and heart tissues of rats submitted to intestinal ischemia

Juliana Christina Calado2, Murched Omar Taha1, Djalma Jose Fagundes1, Hugo Pequeno Monteiro2

1Surgery, Universidade Federal de Sao Paulo-UNIFESP, Sao Paulo, Brazil; 2Biochemical Department, Universidade Federal de Sao Paulo-UNIFESP, Sao Paulo, Brazil

The event of ischemia followed by reperfusion (I/R) promotes injury to the cardiac tissue. I/R are major contributors to cardiac dysfunction and infarct size, and determine patient prognosis after acute myocardial infarction. However, attenuation of the lesions provoked by I/R are achieved by ischemic pre-conditioning (IPC). IPC is defined as a process in which the heart can be protected from an acute lethal I/R injury by applying non-lethal episodes of I/R either to the heart itself or to a distant organ or tissue.In addition, it has been suggested that nitric oxide (NO) and reactive nitrogen species produce a cytoprotection mimicking the action of preconditioning tolerance*.Recently, we described in bradykinin-stimulated endothelial cells a pro-angiogenic and pro-survival signaling pathway. NO synthase (NOS)-derived NO, the epidermal growth factor receptor (EGF-R) and the MAP Kinases ERK1/2 are essential components of this signaling pathway*. In the present communication we sought to determine in 6 month old male Wistar rats submitted to a predefined experimental protocol, whether NO, EGF-R and the ERK1/2 MAP kinases play a role in IPC applied to the mesenteric artery which irrigates the small intestine. Intestine and heart tissues were obtained from sham animals without any treatment, from animals that underwent IPC (5 min ischemia followed by 10 min reperfusion), and from animals submitted to 60 min of ischemia. We then performed histological and western blot analysis of the intestine and heart tissues from the experimental groups. Morphological changes of hematoxylin and eosin stained paraffin sections of the intestine were examined under light microscope. Structures were well preserved in the IPC group, whereas in the ischemia group they were not preserved.Western blot analysis revealed that the expression levels of the EGF-R were elevated in the heart of animals from the IPC group. Expression levels of inducible NOS were elevated in the heart and in the intestine of IPC animals. Expression of phosphorylated ERK1/2 MAP kinases was increased in the intestine of the animals from the IPC group. In conclusion, our data suggest a differential participation of the iNOS, the ERK1/2 MAP kinases, and the EGF-R in the signaling events occurring in heart and intestine tissues from animals submitted to IPC and ischemia compared to animals submitted to ischemia.  
Financial Support: CNPq and FAPESP/Brazil


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada